OHSU cancer institute researcher discovers new predictor of prostate cancer ...( PORTLAND Ore. An Oregon Health & Scien...),Health
Navigation Links
OHSU cancer institute researcher discovers new predictor of prostate cancer recurrence
Date:2/14/2008
PORTLAND, Ore. An Oregon Health & Science University Cancer Institute researcher has found a biomarker that may help improve the ability to predict if a mans prostate cancer is going to come back after surgical removal.
In order to make this discovery, researchers examined prostate cancer tissue samples that had been removed during surgical procedures on cancer patients. The researchers found that men whose tumors showed a silencing of the gene CDH13 had a five-fold increased risk of prostate cancer recurrence compared with men whose tumors showed no silencing of this gene, according to Joshi Alumkal, M.D., OHSU Cancer Institute member and assistant professor of medicine, (hematology/medical oncology), OHSU School of Medicine. In normal cells, this gene is active, but in some cancer cells it may be turned off, which leads to a propensity for metastasis, or spreading.
The research, DNA Methylation as a Predictor of Prostate Cancer Recurrence, will be presented as a poster on Thursday, Feb. 14, from 11:30 a.m. to 12:30 p.m. at the 2008 American Society of Clinical Oncology Genitourinary Symposium in San Francisco.
In this study, the largest of its kind examining DNA methylation changes and prostate cancer recurrence, the research team looked at tissue samples from 151 research subjects with localized prostate cancer with at least five years of follow-up after their prostatectomies. During prostate cancer formation, the DNA may be modified through a process called DNA methylation, which turns off many important genes called tumor suppressor genes that act as the brakes on cancer cell growth or cancer cell spread. CDH13 is a prime example of one of these genes.
Two-thirds of the subjects were free of recurrence; one-third had a recurrence.
In the clinic, those of us who care for patients with prostate cancer look at the pathology report and PSA blood test to determine how a patient will do after surgery and how aggr
'/>"/>
| Contact: Christine Decker deckerch@ohsu.edu 503-494-6397 Oregon Health & Science University Source:Eurekalert |
Related medicine news :
1. DDT Compound Speeds Breast Cancer Growth
2. Secretary Norman Y. Mineta Joins Lung Cancer Alliance Board of Directors
3. The Facts African Americans Need to Know About Colon Cancer
4. How DDT metabolite disrupts breast cancer cells
5. Climb to Fight Breast Cancer Offers Peaks for Every Skill Level
6. Patient with rare disorder responds to cancer drug
7. Cancer Drug Works Against MS in Early Trial
8. American Cancer Society honors exemplary cancer caregivers
9. Smokers might benefit from earlier colon cancer screening
10. Scientists solve structure of gene regulator that plays key role in cancer
11. Sun Busters(R) Now Sports The Skin Cancer Foundations Seal of Recommendation
Post Your Comments:
(Date:11/24/2009)... Along with his state-of-the-ar...and social media to interact with patients and sha...urgery practice and the procedures that he offers... November 24, 2009 -- North Carolina plastic surg...ocial networking site Facebook to expand his reach...
(Date:11/24/2009)... Two expert therapists offer ad...ers. a - ban,- don: verb: to leave completely and... Vancouver, Canada (Vocus) November ...to today announced the second webinar is its groun...Therapy" series from MyShrink.com ( http://ww...
(Date:11/24/2009)... Tattoo Removal Laser Clinic, l... in America, Corporal Jason, with his new modeling...e time he begins modeling full time in the middle ...November 24, 2009 -- Tattoo Removal Laser Clinic, ...e in America, Corporal Jason, with his new modelin...
(Date:11/24/2009)..., WASHINGTON,Nov.24/PRNewswire-USNewswire/--Newpee...arly4millionAmericansinfectedwithchronichepatitisC...uldbeawake-upcallthatCongressneedstomoveurgentlyon...ion,research,andsurveillanceefforts,the NationalVi...VHRwarnsthatwithoutcongressionalaction,millionsofA...
(Date:11/23/2009)...cent metobolomics study by researchers from Virgin...ond found that impaired peroxisomal oxidation of p...th the progression of nonalcoholic fatty liver (NA...study also found significantly higher plasma monou...th NAFL and NASH. Full findings appear in the Dec...
Breaking Medicine News(10 mins):Health News:North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community 2Health News:North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community 3Health News:Home For the Holidays: MyShrink.com Announces the Second in its Successful Six-Part Webinar Series: "Abandonment: The Hidden Fear" 2Health News:Tattoo Removal on the Fastest U.S. Marine 2Health News:NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 2Health News:Metobolomics uncovers key indicators of nonalcoholic fatty liver disease 2[0] North Carolina Plastic Surgeon Embracing Social Media to Connect with Patients and Reach Out to Community[0] Home For the Holidays: MyShrink.com Announces the Second in its Successful Six-Part Webinar Series: "Abandonment: The Hidden Fear"[0] Tattoo Removal on the Fastest U.S. Marine[0] NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington[0] Metobolomics uncovers key indicators of nonalcoholic fatty liver disease
...ion Relief to All Rhode Island Residents , , P...s now have an ally to help them fight off rising h...tion drug card program, called RIRx , is schedule...e roughly 30%). , , Rhode Island residents can d...
...sing real-time communication tools like instant me...lity of sales reps to engage with physicians. , ,...i-tasking makes them more efficient," stated a sal...ur things at once that the quality of their work a...
..., Mass. and SYDNEY, Australia, March 26 Thoratec ...based mechanical circulatory support therapies to ...tWare International, Inc. (Nasdaq: HTWR ; ASX: H...n, or a "second request," from the United States F...
... Comerica Debt Facilities; Support Robust Growth ,... , (Nasdaq: CLRT ), a premier anatomic pathology...logists, oncologists and the pharmaceutical indust... venture capital firm with $8.4 billion in committ...
...Hopkins University School of Medicine have been na...edical Institute (HHMI). Xinzhong Dong, Ph.D., Jos... all will remain faculty at Hopkins but also becom...recognized by Hughes for the quality of their work...
...lars to Pay for Umbilical Cord Blood Banking , , ...(CBR) , the global leader in the collection and pr...rd blood, announced its support of legislation int...entitled the "Family Cord Blood Banking Act." Thi...
Other Medicine News:Health News:Free Prescription Drug Card Launched in Rhode Island 2Health News:Sales Force Effectiveness: Less Texting, More Engagement 2Health News:Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission 2Health News:Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission 3Health News:Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission 4Health News:Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission 5Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 2Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 3Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 4Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 5Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 6Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 7Health News:Clarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment Partners 8Health News:Three Johns Hopkins researchers named Howard Hughes Medical Institute early career scientists 2Health News:Cord Blood Registry Supports Family Cord Blood Banking Act 2Health News:Cord Blood Registry Supports Family Cord Blood Banking Act 3Free Prescription Drug Card Launched in Rhode IslandSales Force Effectiveness: Less Texting, More EngagementThoratec and HeartWare Receive Request for Additional Information From Federal Trade CommissionClarient Entered Into Private Placement of Up To $50 Million in Convertible Preferred Stock With Oak Investment PartnersThree Johns Hopkins researchers named Howard Hughes Medical Institute early career scientistsCord Blood Registry Supports Family Cord Blood Banking Act
(Date:11/23/2009)... ,, WASHINGTON,Nov.23/PRNewswire-USNewswire/...uiltyonNov.20,2009,toparticipatinginaschemetodefra...ofmorethan$1million,announcedAssistantAttorneyGene...ectorGeneralOsvaldoL.GratacosoftheEx-ImBank,Office...eforeJudgeRichardW.RobertsinU.S.DistrictCourtinWas...
(Date:11/23/2009)... ,, NORCROSS,Ga.,Nov.23/PRNewswire-FirstCall...idingautomatedinstrument-reagentsystemstothebloodt...esentationatthePiperJaffray21stAnnualHealthCareCon...neouswebcast. ,, TheCompany,spresentationissche...ime.Accesstothepresentationwillbeavailablethrought...
(Date:11/23/2009)... ,, THOUSANDOAKS,Calif.,Nov.23/PRNewswire-Fi...9ScripAwards,winningforBestOverallPipelineandforBe...emonyinLondon. ,, TheBestOverallPipelineawardwa...lity,noveltyandmarketpotentialofthecompany,spipeli...es.Accordingtothejudges,Amgen,spipelineisnotablefo...
Breaking Medicine Technology:Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Childrens Hospital Los Angeles Completes Conversion to Masimo SET 28R 29 Pulse Oximetry Technology 55313 1Childrens Hospital Los Angeles Completes Conversion to Masimo SET 28R 29 Pulse Oximetry Technology 55313 2Childrens Hospital Los Angeles Completes Conversion to Masimo SET 28R 29 Pulse Oximetry Technology 55313 3Childrens Hospital Los Angeles Completes Conversion to Masimo SET 28R 29 Pulse Oximetry Technology 55313 4Childrens Hospital Los Angeles Completes Conversion to Masimo SET 28R 29 Pulse Oximetry Technology 55313 5Schwarzeneggers Budget Cuts Force Closure of California AIDS Clearinghouse 55311 1Schwarzeneggers Budget Cuts Force Closure of California AIDS Clearinghouse 55311 2Nottingham scientists commissioned for urgent swine flu research 55306 1Nottingham scientists commissioned for urgent swine flu research 55306 2...NO, Calif., May 27 Epeius Biotechnologies,( http:... results of a Phase,I Feasibility Study of sequent...ed by Reximmune-C -- for cancer vaccination will b...e 1, 2008 (J Clin Oncol 26:3077, 2008).,Rexin-G an...noparticles,bearing a cytocidal cyclin G1 gene and...
...ON DC, May 27 Bavarian Nordic, the,Danish-based b...II clinical,study with its HIV vaccine candidate: ... I/II safety and immunogenicity study in 15,HIV-in...gun in the United,States. The first safety data is...ta will be available during first half of 2009., ...
Other Medicine Technology:TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008) 2TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008) 3Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine 2The Natural-Hip Family - Revision/Trauma Nonporous CoCr
MARATHON Cross Linked Polyethylene Acetabular Liner
Ringloc Acetabular Liners
Olympia Total Shoulder System
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |